Microbial Chemistry Research Foundation
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
1
Ending by 2030
Aug 2029
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Nov 26, 2026The maintenance fee for Anti-XDR-TB drug, anti-MDR-TB drug, and combination anti-tuberculosis drug (US 9,040,502) comes due Nov 26, 2026. Unpaid by May 26, 2027, it lapses early.
- 1 fee due Jan 14, 2027The maintenance fee for Microorganism belonging to genus Bacillus, thrombolytic enzyme, and method for treating waste (US 9,079,229) comes due Jan 14, 2027. Unpaid by Jul 14, 2027, it lapses early.
- 1 fee due Mar 17, 2027The maintenance fee for Catalyst, production method therefor, and method for producing optically active anti-1, 2-nitroalkanol compound (US 10,413,892) comes due Mar 17, 2027. Unpaid by Sep 17, 2027, it lapses early.
- 1 fee due Oct 14, 2027The maintenance fee for Effective aminoglycoside antibiotic for multidrug-resistant bacteria (US 10,617,704) comes due Oct 14, 2027. Unpaid by Apr 14, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,263,369 | Compound ceramidastin, method for producing the same, and use of the same In force (reinstated) · From the USPTO record | In force (reinstated) | From the USPTO record | |
| US 9,079,229 | Microorganism belonging to genus Bacillus, thrombolytic enzyme, and method for treating waste In force · From the USPTO record | In force | From the USPTO record | |
| US 9,440,871 | Treatment agent for salt-containing organic waste liquid, salt concentration-reducing agent, treatment method for salt-containing organic waste liquid, and entrapment immobilization carrier In force · From the USPTO record | In force | From the USPTO record | |
| US 9,040,502 | Anti-XDR-TB drug, anti-MDR-TB drug, and combination anti-tuberculosis drug In force · From the USPTO record | In force | From the USPTO record | |
| US 9,416,189 | Anti-CXADR antibody In force · From the USPTO record | In force | From the USPTO record | |
| US 9,512,075 | Compound; tautomer and geometric isomer thereof; salt of said compound, tautomer, or geometric isomer; method for manufacturing said compound, tautomer, isomer, or salt; antimicrobial agent; and anti-infective drug In force · From the USPTO record | In force | From the USPTO record | |
| US 9,901,913 | Catalyst and method for producing optically active anti-1,2-nitroalkanol compound In force · From the USPTO record | In force | From the USPTO record | |
| US 9,617,217 | Compound, production method therefor, and use of said compound In force · From the USPTO record | In force | From the USPTO record | |
| US 9,850,211 | Compound, production method therefor, and use of said compound In force · From the USPTO record | In force | From the USPTO record | |
| US 10,202,347 | Novel Compound, Production Method Therefor, and Use of Said Compound In force · Low confidence | In force | Low confidence |
Also on record, not counted in the 15: 24 lapsed for an unpaid fee · 6 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 pending · 3 abandoned · 5 no status recorded